REVIEW ON SEASONAL INCIDENCE OF PSORIASIS EXACERBATIONS DURING WINTER IN INDIA: CLINICAL INSIGHTS AND OBSERVATIONS
Main Article Content
Keywords
Psoriasis, TNF, plaque, seasonal, pustular, climatotherapy.
Abstract
The cause of a disease over approximately 125 million people worldwide with active cases of psoriasis. The patients with the disease psoriasis experience substantial morbidity and increased rates of inflammatory arthritis, cardiometabolic diseases, and mental health disorders. As per the data published on the site of WHO Global report on psoriasis that a new comprehensive worldwide systematic review of the epidemiology of psoriasis was undertaken. Psoriasis is a common disease, occurring more frequently with advancing age and as per the data of the researches it was estimated that the prevalence of psoriasis in adults ranged from 0.53% to 11.48%, and in children from 0.5 % to 1.40%. The available data comes from approximately 20 countries, there is a vast difference of knowledge in low and middle income settings. As it was conducted by several sources about the increase in the number of active cases so in this article we rigorously and systematically analyze the research work. This article contain all the nursery information related to the disease psoriasis and also with the advance treatments and recent advancements.
References
1. Smith CH, Barker JN. Psoriasis and its management. Bmj. 2006 Aug 17; 333(7564):380-4.
2. Raharja A, Mahil SK, Barker JN. Psoriasis: a brief overview. Clinical Medicine. 2021 May 1; 21(3):170-3.
3. Kuchekar AB, Pujari RR, Kuchekar SB, Dhole SN, Mule PM, Vidyapeeth B, Wadi B. Psoriasis: A comprehensive review. Int J Pharm Life Sci. 2011 Jun; 2(6):857-77.
4. Agarwal K, Das S, Kumar R, De A. Psoriasis and its association with metabolic syndrome. Indian Journal of Dermatology. 2023 May 1; 68(3):274-7.
5. Jensen KK, Serup J, Alsing KK. Psoriasis and seasonal variation: a systematic review on reports from Northern and Central Europe—little overall variation but distinctive subsets with improvement in summer or wintertime. Skin Research and Technology. 2022 Jan; 28(1):180-6.
6. Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. Journal of the American Academy of Dermatology. 1985 Sep 1; 13(3):450-6.
7. Vol. 1-78 (1893-1938) were published under the journal's former title Dermatologische Zeitschrift and Vol. 79-183 (1939-1991) under Dermatologica.
8. Kumar S, Nayak CS, Padhi T, Rao G, Rao A, Sharma VK, Srinivas CR. Epidemiological pattern of psoriasis, vitiligo and atopic dermatitis in India: Hospital-based point prevalence. Indian dermatology online journal. 2014 Nov 1; 5(Suppl 1): S6-8.
9. Bedi T R. Clinical profile of psoriasis in North India. Indian J Dermatol Venereol Leprol 1995; 61:202-205
10. Dhabale A, Nagpure S. Types of psoriasis and their effects on the immune system. Cureus. 2022 Sep; 14(9).
11. MacDonald A, Burden AD. Psoriasis: advances in pathophysiology and management. Postgraduate medical journal. 2007 Nov; 83(985):690-7.
12. Creamer D, Allen MH, Sousa A, Poston R, Barker JN. Localization of endothelial proliferation and microvascular expansion in active plaque psoriasis. British Journal of Dermatology. 1997 Jun; 136(6):859-65.
13. Xia YP, Li B, Hylton D, Detmar M, Yancopoulos GD, Rudge JS. Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood. 2003 Jul 1; 102(1):161-8.
14. Bhushan M, McLaughlin B, Weiss JB, Griffiths CE. Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis. British Journal of Dermatology. 1999 Dec 1; 141(6):1054-60.
15. Snowden JA, Heaton DC. Development of psoriasis after syngeneic bone marrow transplant from psoriatic donor: further evidence for adoptive autoimmunity. British Journal of Dermatology. 1997 Jul 1; 137(1):130-2
16. Boyman O, Hefti HP, Conrad C, Nickoloff BJ, Suter M, Nestle FO. Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-α. The Journal of experimental medicine. 2004 Mar 1; 199(5):731-6.
17. Kauffman CL, Aria N, Toichi E, mccormick TS, Cooper KD, Gottlieb AB, Everitt DE, Frederick B, Zhu Y, Graham MA, Pendley CE. A phase I study evaluating the safety, pharmacokinetics, and clinical response of a human IL-12 p40 antibody in subjects with plaque psoriasis. Journal of Investigative Dermatology. 2004 Dec 1; 123(6):1037-44.
18. Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, Wu J, Ouyang W. Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature. 2007 Feb 8; 445(7128):648-51.
19. Mussi A, Bonifati C, Carducci M, D'Agosto G, Pimpinelli F, D'Urso D, D'Auria L, Fazio M, Ameglio F. Serum TNF-alpha levels correlate with disease severity and are reduced by effective therapy in plaque-type psoriasis. Journal of biological regulators and homeostatic agents. 1997 Jul 1; 11(3):115-8.
20. Cameron AL, Kirby B, Griffiths CE. Circulating natural killer cells in psoriasis. British Journal of Dermatology. 2003 Jul 1; 149(1):160-4.
21. Baker BS, Ovigne JM, Powles AV, Corcoran S, Fry L. Normal keratinocytes express Toll‐like receptors (tlrs) 1, 2 and 5: modulation of TLR expression in chronic plaque psoriasis. British Journal of Dermatology. 2003 Apr 1; 148(4):670-9.
22. Musumeci ML, Nasca MR, Boscaglia S, Micali G. The role of lifestyle and nutrition in psoriasis: Current status of knowledge and interventions. Dermatologic Therapy. 2022 Sep; 35(9): e15685.
23. Zhu Kj, Zhu cy, Fan Ym. Alcohol consumption and psoriatic risk: a meta‐analysis of case–control studies. The Journal of dermatology. 2012 Sep; 39(9):770-3.
24. Zuccotti E, Oliveri M, Ratto D, Di Iorio C, Occhinegro A, Rossi P, girometta C. Nutritional strategies for psoriasis: current scientific evidence in clinical trials. European Review for Medical & Pharmacological Sciences. 2018 Dec 1; 22(23).
25. Madden SK, Flanagan KL, Jones G. How lifestyle factors and their associated pathogenetic mechanisms impact psoriasis. Clinical Nutrition. 2020 Apr 1; 39(4):1026-40.
26. Armstrong AW, Harskamp CT, Dhillon JS, Armstrong EJ. Psoriasis and smoking: a systematic review and meta‐analysis. British journal of dermatology. 2014 Feb 1; 170(2):304-14.
27. Katsimbri P, Korakas E, Kountouri A, Ikonomidis I, Tsougos E, Vlachos D, Papadavid E, Raptis A, Lambadiari V. The effect of antioxidant and anti-inflammatory capacity of diet on psoriasis and psoriatic arthritis phenotype: nutrition as therapeutic tool. Antioxidants. 2021 Jan 22; 10(2):157.
28. Pacifico A, Conic RR, Cristaudo A, Garbarino S, Ardigò M, Morrone A, Iacovelli P, di Gregorio S, Pigatto PD, Grada A, Feldman SR. Diet-related phototoxic reactions in psoriatic patients undergoing phototherapy: results from a multicenter prospective study. Nutrients. 2021 Aug 25; 13(9):2934.
29. Rastmanesh R. Psoriasis and vegetarian diets: a role for cortisol and potassium. Medical hypotheses. 2009; 3(72):368.
30. Tsai TY, Yen H, Huang YC. Serum homocysteine, folate and vitamin B12 levels in patients with psoriasis: a systematic review and meta‐analysis. British Journal of Dermatology. 2019 Feb 1; 180(2):382-9.
31. Fujita H, Gooderham M, Romiti R. Diagnosis of generalized pustular psoriasis. American Journal of Clinical Dermatology. 2022 Jan; 23(Suppl 1):31-8.
32. Ly K, Beck KM, Smith MP, Thibodeaux Q, Bhutani T. Diagnosis and screening of patients with generalized pustular psoriasis. Psoriasis: Targets and Therapy. 2019 Jun 20:37-42.
33. Tobin AM, Langan SM, Collins P, Kirby B. Generalized pustular psoriasis (von Zumbusch) following the use of calcipotriol and betamethasone dipropionate ointment: a report of two cases. Clinical and experimental dermatology. 2009 Jul 1; 34(5):629-30.
34. Katz M, Seidenbaum M, Weinrauch L. Penicillin-induced generalized pustular psoriasis. Journal of the American Academy of Dermatology. 1987 Nov 1; 17(5):918-20.
35. Samotij D, Szczęch J, Reich A. Generalized pustular psoriasis: divergence of innate and adaptive immunity. International Journal of Molecular Sciences. 2021 Aug 22; 22(16):9048.
36. Micali G, Verzì AE, Giuffrida G, Panebianco E, Musumeci ML, Lacarrubba F. Inverse psoriasis: from diagnosis to current treatment options. Clinical, cosmetic and investigational dermatology. 2019 Dec 31:953-9.
37. Negrutiu M, Danescu S, Popa T, Focsan M, Vesa SC, Szasz F, Baican A. Imaging Approach in the Diagnostics and Evaluation of the Psoriasis Plaque: A Preliminary Study and Literature Review. Diagnostics. 2024 May 7; 14(10):969.
38. Grajdeanu IA, Statescu L, Vata D, Popescu IA, Porumb-Andrese E, Patrascu AI, Taranu T, Crisan M, Solovastru LG. Imaging techniques in the diagnosis and monitoring of psoriasis. Experimental and therapeutic medicine. 2019 Dec; 18(6):4974-80.
39. Errichetti E, Stinco G. Dermoscopy in general dermatology: a practical overview. Dermatology and therapy. 2016 Dec; 6:471-507.
40. Tokuyama M, Mabuchi T. New treatment addressing the pathogenesis of psoriasis. International journal of molecular sciences. 2020 Oct 11; 21(20):7488.
41. Ogawa E, Sato Y, Minagawa A, Okuyama R. Pathogenesis of psoriasis and development of treatment. The Journal of dermatology. 2018 Mar; 45(3):264-72.
42. Raaby L, Zachariae C, Østensen M, Heickendorff L, Thielsen P, Grønbæk H, Skov L, Kyvsgaard N, Madsen JT, Heidenheim M, Funding AT. Methotrexate use and monitoring in patients with psoriasis: a consensus report based on a Danish expert meeting. Acta dermato-venereologica. 2017; 97(4):426-32.
43. Maza A, Montaudié H, Sbidian E, Gallini A, Aractingi S, Aubin F, Bachelez H, Cribier B, Joly P, Jullien D, Le Maître M. Oral cyclosporin in psoriasis: a systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non‐plaque psoriasis. Journal of the European Academy of Dermatology and Venereology. 2011 May; 25:19-27.
44. Gall JS, Kalb RE. Infliximab for the treatment of plaque psoriasis. Biologics: Targets and Therapy. 2008 Mar 1; 2(1):115-24.
45. Bachelez H, Choon SE, Marrakchi S, Burden AD, Tsai TF, Morita A, Turki H, Hall DB, Shear M, Baum P, Padula SJ. Inhibition of the interleukin-36 pathway for the treatment of generalized pustular psoriasis. New England Journal of Medicine. 2019 Mar 7; 380(10):981-3.
46. Papp KA, Menter MA, Abe M, Elewski B, Feldman SR, Gottlieb AB, Langley R, Luger T, Thaci D, Buonanno M, and Gupta P. Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo‐controlled, phase III trials. British Journal of Dermatology. 2015 Oct 1; 173(4):949-61.
47. Bissonnette R, Iversen L, Sofen H, Griffiths CE, Foley P, Romiti R, Bachinsky M, Rottinghaus ST, Tan H, Proulx J, Valdez H. Tofacitinib withdrawal and retreatment in moderate‐to‐severe chronic plaque psoriasis: a randomized controlled trial. British Journal of Dermatology. 2015 May 1; 172(5):1395-406.
48. Garg T, Rath G, Goyal AK. Nanotechnological approaches for the effective management of psoriasis. Artificial Cells, Nanomedicine, and Biotechnology. 2016 Aug 17; 44(6):1374-82.
49. Hazari SA, Kaur H, Karwasra R, Abourehab MA, Khan AA, Kesharwani P. An overview of topical lipid-based and polymer-based nanocarriers for treatment of psoriasis. International Journal of Pharmaceutics. 2023 May 10; 638:122938.
50. Gupta R, Gupta M, Mangal S, Agrawal U, Vyas SP. Capsaicin-loaded vesicular systems designed for enhancing localized delivery for psoriasis therapy. Artificial cells, nanomedicine, and biotechnology. 2016 Apr 2; 44(3):825-34.
51. Carter RB. Topical capsaicin in the treatment of cutaneous disorders. Drug development research. 1991; 22(2):109-23.
52. Park MK, Li W, Paek SY, Li X, Wu S, Li T, Qureshi AA, Cho E. Consumption of polyunsaturated fatty acids and risk of incident psoriasis and psoriatic arthritis from the Nurses’ Health Study II. British Journal of Dermatology. 2017 Jul 1; 177(1):302-6.
53. Wolters M. Diet and psoriasis: experimental data and clinical evidence. British Journal of Dermatology. 2005 Oct 1; 153(4):706-14.
2. Raharja A, Mahil SK, Barker JN. Psoriasis: a brief overview. Clinical Medicine. 2021 May 1; 21(3):170-3.
3. Kuchekar AB, Pujari RR, Kuchekar SB, Dhole SN, Mule PM, Vidyapeeth B, Wadi B. Psoriasis: A comprehensive review. Int J Pharm Life Sci. 2011 Jun; 2(6):857-77.
4. Agarwal K, Das S, Kumar R, De A. Psoriasis and its association with metabolic syndrome. Indian Journal of Dermatology. 2023 May 1; 68(3):274-7.
5. Jensen KK, Serup J, Alsing KK. Psoriasis and seasonal variation: a systematic review on reports from Northern and Central Europe—little overall variation but distinctive subsets with improvement in summer or wintertime. Skin Research and Technology. 2022 Jan; 28(1):180-6.
6. Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. Journal of the American Academy of Dermatology. 1985 Sep 1; 13(3):450-6.
7. Vol. 1-78 (1893-1938) were published under the journal's former title Dermatologische Zeitschrift and Vol. 79-183 (1939-1991) under Dermatologica.
8. Kumar S, Nayak CS, Padhi T, Rao G, Rao A, Sharma VK, Srinivas CR. Epidemiological pattern of psoriasis, vitiligo and atopic dermatitis in India: Hospital-based point prevalence. Indian dermatology online journal. 2014 Nov 1; 5(Suppl 1): S6-8.
9. Bedi T R. Clinical profile of psoriasis in North India. Indian J Dermatol Venereol Leprol 1995; 61:202-205
10. Dhabale A, Nagpure S. Types of psoriasis and their effects on the immune system. Cureus. 2022 Sep; 14(9).
11. MacDonald A, Burden AD. Psoriasis: advances in pathophysiology and management. Postgraduate medical journal. 2007 Nov; 83(985):690-7.
12. Creamer D, Allen MH, Sousa A, Poston R, Barker JN. Localization of endothelial proliferation and microvascular expansion in active plaque psoriasis. British Journal of Dermatology. 1997 Jun; 136(6):859-65.
13. Xia YP, Li B, Hylton D, Detmar M, Yancopoulos GD, Rudge JS. Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood. 2003 Jul 1; 102(1):161-8.
14. Bhushan M, McLaughlin B, Weiss JB, Griffiths CE. Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis. British Journal of Dermatology. 1999 Dec 1; 141(6):1054-60.
15. Snowden JA, Heaton DC. Development of psoriasis after syngeneic bone marrow transplant from psoriatic donor: further evidence for adoptive autoimmunity. British Journal of Dermatology. 1997 Jul 1; 137(1):130-2
16. Boyman O, Hefti HP, Conrad C, Nickoloff BJ, Suter M, Nestle FO. Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-α. The Journal of experimental medicine. 2004 Mar 1; 199(5):731-6.
17. Kauffman CL, Aria N, Toichi E, mccormick TS, Cooper KD, Gottlieb AB, Everitt DE, Frederick B, Zhu Y, Graham MA, Pendley CE. A phase I study evaluating the safety, pharmacokinetics, and clinical response of a human IL-12 p40 antibody in subjects with plaque psoriasis. Journal of Investigative Dermatology. 2004 Dec 1; 123(6):1037-44.
18. Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, Wu J, Ouyang W. Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature. 2007 Feb 8; 445(7128):648-51.
19. Mussi A, Bonifati C, Carducci M, D'Agosto G, Pimpinelli F, D'Urso D, D'Auria L, Fazio M, Ameglio F. Serum TNF-alpha levels correlate with disease severity and are reduced by effective therapy in plaque-type psoriasis. Journal of biological regulators and homeostatic agents. 1997 Jul 1; 11(3):115-8.
20. Cameron AL, Kirby B, Griffiths CE. Circulating natural killer cells in psoriasis. British Journal of Dermatology. 2003 Jul 1; 149(1):160-4.
21. Baker BS, Ovigne JM, Powles AV, Corcoran S, Fry L. Normal keratinocytes express Toll‐like receptors (tlrs) 1, 2 and 5: modulation of TLR expression in chronic plaque psoriasis. British Journal of Dermatology. 2003 Apr 1; 148(4):670-9.
22. Musumeci ML, Nasca MR, Boscaglia S, Micali G. The role of lifestyle and nutrition in psoriasis: Current status of knowledge and interventions. Dermatologic Therapy. 2022 Sep; 35(9): e15685.
23. Zhu Kj, Zhu cy, Fan Ym. Alcohol consumption and psoriatic risk: a meta‐analysis of case–control studies. The Journal of dermatology. 2012 Sep; 39(9):770-3.
24. Zuccotti E, Oliveri M, Ratto D, Di Iorio C, Occhinegro A, Rossi P, girometta C. Nutritional strategies for psoriasis: current scientific evidence in clinical trials. European Review for Medical & Pharmacological Sciences. 2018 Dec 1; 22(23).
25. Madden SK, Flanagan KL, Jones G. How lifestyle factors and their associated pathogenetic mechanisms impact psoriasis. Clinical Nutrition. 2020 Apr 1; 39(4):1026-40.
26. Armstrong AW, Harskamp CT, Dhillon JS, Armstrong EJ. Psoriasis and smoking: a systematic review and meta‐analysis. British journal of dermatology. 2014 Feb 1; 170(2):304-14.
27. Katsimbri P, Korakas E, Kountouri A, Ikonomidis I, Tsougos E, Vlachos D, Papadavid E, Raptis A, Lambadiari V. The effect of antioxidant and anti-inflammatory capacity of diet on psoriasis and psoriatic arthritis phenotype: nutrition as therapeutic tool. Antioxidants. 2021 Jan 22; 10(2):157.
28. Pacifico A, Conic RR, Cristaudo A, Garbarino S, Ardigò M, Morrone A, Iacovelli P, di Gregorio S, Pigatto PD, Grada A, Feldman SR. Diet-related phototoxic reactions in psoriatic patients undergoing phototherapy: results from a multicenter prospective study. Nutrients. 2021 Aug 25; 13(9):2934.
29. Rastmanesh R. Psoriasis and vegetarian diets: a role for cortisol and potassium. Medical hypotheses. 2009; 3(72):368.
30. Tsai TY, Yen H, Huang YC. Serum homocysteine, folate and vitamin B12 levels in patients with psoriasis: a systematic review and meta‐analysis. British Journal of Dermatology. 2019 Feb 1; 180(2):382-9.
31. Fujita H, Gooderham M, Romiti R. Diagnosis of generalized pustular psoriasis. American Journal of Clinical Dermatology. 2022 Jan; 23(Suppl 1):31-8.
32. Ly K, Beck KM, Smith MP, Thibodeaux Q, Bhutani T. Diagnosis and screening of patients with generalized pustular psoriasis. Psoriasis: Targets and Therapy. 2019 Jun 20:37-42.
33. Tobin AM, Langan SM, Collins P, Kirby B. Generalized pustular psoriasis (von Zumbusch) following the use of calcipotriol and betamethasone dipropionate ointment: a report of two cases. Clinical and experimental dermatology. 2009 Jul 1; 34(5):629-30.
34. Katz M, Seidenbaum M, Weinrauch L. Penicillin-induced generalized pustular psoriasis. Journal of the American Academy of Dermatology. 1987 Nov 1; 17(5):918-20.
35. Samotij D, Szczęch J, Reich A. Generalized pustular psoriasis: divergence of innate and adaptive immunity. International Journal of Molecular Sciences. 2021 Aug 22; 22(16):9048.
36. Micali G, Verzì AE, Giuffrida G, Panebianco E, Musumeci ML, Lacarrubba F. Inverse psoriasis: from diagnosis to current treatment options. Clinical, cosmetic and investigational dermatology. 2019 Dec 31:953-9.
37. Negrutiu M, Danescu S, Popa T, Focsan M, Vesa SC, Szasz F, Baican A. Imaging Approach in the Diagnostics and Evaluation of the Psoriasis Plaque: A Preliminary Study and Literature Review. Diagnostics. 2024 May 7; 14(10):969.
38. Grajdeanu IA, Statescu L, Vata D, Popescu IA, Porumb-Andrese E, Patrascu AI, Taranu T, Crisan M, Solovastru LG. Imaging techniques in the diagnosis and monitoring of psoriasis. Experimental and therapeutic medicine. 2019 Dec; 18(6):4974-80.
39. Errichetti E, Stinco G. Dermoscopy in general dermatology: a practical overview. Dermatology and therapy. 2016 Dec; 6:471-507.
40. Tokuyama M, Mabuchi T. New treatment addressing the pathogenesis of psoriasis. International journal of molecular sciences. 2020 Oct 11; 21(20):7488.
41. Ogawa E, Sato Y, Minagawa A, Okuyama R. Pathogenesis of psoriasis and development of treatment. The Journal of dermatology. 2018 Mar; 45(3):264-72.
42. Raaby L, Zachariae C, Østensen M, Heickendorff L, Thielsen P, Grønbæk H, Skov L, Kyvsgaard N, Madsen JT, Heidenheim M, Funding AT. Methotrexate use and monitoring in patients with psoriasis: a consensus report based on a Danish expert meeting. Acta dermato-venereologica. 2017; 97(4):426-32.
43. Maza A, Montaudié H, Sbidian E, Gallini A, Aractingi S, Aubin F, Bachelez H, Cribier B, Joly P, Jullien D, Le Maître M. Oral cyclosporin in psoriasis: a systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non‐plaque psoriasis. Journal of the European Academy of Dermatology and Venereology. 2011 May; 25:19-27.
44. Gall JS, Kalb RE. Infliximab for the treatment of plaque psoriasis. Biologics: Targets and Therapy. 2008 Mar 1; 2(1):115-24.
45. Bachelez H, Choon SE, Marrakchi S, Burden AD, Tsai TF, Morita A, Turki H, Hall DB, Shear M, Baum P, Padula SJ. Inhibition of the interleukin-36 pathway for the treatment of generalized pustular psoriasis. New England Journal of Medicine. 2019 Mar 7; 380(10):981-3.
46. Papp KA, Menter MA, Abe M, Elewski B, Feldman SR, Gottlieb AB, Langley R, Luger T, Thaci D, Buonanno M, and Gupta P. Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo‐controlled, phase III trials. British Journal of Dermatology. 2015 Oct 1; 173(4):949-61.
47. Bissonnette R, Iversen L, Sofen H, Griffiths CE, Foley P, Romiti R, Bachinsky M, Rottinghaus ST, Tan H, Proulx J, Valdez H. Tofacitinib withdrawal and retreatment in moderate‐to‐severe chronic plaque psoriasis: a randomized controlled trial. British Journal of Dermatology. 2015 May 1; 172(5):1395-406.
48. Garg T, Rath G, Goyal AK. Nanotechnological approaches for the effective management of psoriasis. Artificial Cells, Nanomedicine, and Biotechnology. 2016 Aug 17; 44(6):1374-82.
49. Hazari SA, Kaur H, Karwasra R, Abourehab MA, Khan AA, Kesharwani P. An overview of topical lipid-based and polymer-based nanocarriers for treatment of psoriasis. International Journal of Pharmaceutics. 2023 May 10; 638:122938.
50. Gupta R, Gupta M, Mangal S, Agrawal U, Vyas SP. Capsaicin-loaded vesicular systems designed for enhancing localized delivery for psoriasis therapy. Artificial cells, nanomedicine, and biotechnology. 2016 Apr 2; 44(3):825-34.
51. Carter RB. Topical capsaicin in the treatment of cutaneous disorders. Drug development research. 1991; 22(2):109-23.
52. Park MK, Li W, Paek SY, Li X, Wu S, Li T, Qureshi AA, Cho E. Consumption of polyunsaturated fatty acids and risk of incident psoriasis and psoriatic arthritis from the Nurses’ Health Study II. British Journal of Dermatology. 2017 Jul 1; 177(1):302-6.
53. Wolters M. Diet and psoriasis: experimental data and clinical evidence. British Journal of Dermatology. 2005 Oct 1; 153(4):706-14.
Article Sidebar
Published
Dec 11, 2024
Article Details
How to Cite
Dhwiti Patel, Ms. Sonika Rathi, & Dr. Pragnesh Patani. (2024). REVIEW ON SEASONAL INCIDENCE OF PSORIASIS EXACERBATIONS DURING WINTER IN INDIA: CLINICAL INSIGHTS AND OBSERVATIONS. Journal of Population Therapeutics and Clinical Pharmacology, 31(11), 1208-1217. https://doi.org/10.53555/wsfm2880
Section
Articles
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Author Biographies
Dhwiti Patel
Khyati College of Pharmacy, Palodia, Ahmedabad
Ms. Sonika Rathi
Assistant Professor, Department of Pharmacology, Khyati College of Pharmacy, Palodia, Ahmedabad
Dr. Pragnesh Patani
Principal, Khyati College of Pharmacy, Palodia, Ahmedabad
How to Cite
Dhwiti Patel, Ms. Sonika Rathi, & Dr. Pragnesh Patani. (2024). REVIEW ON SEASONAL INCIDENCE OF PSORIASIS EXACERBATIONS DURING WINTER IN INDIA: CLINICAL INSIGHTS AND OBSERVATIONS. Journal of Population Therapeutics and Clinical Pharmacology, 31(11), 1208-1217. https://doi.org/10.53555/wsfm2880